(주)화이바이오메드

{
  "address": "서울 강남구",
  "ceo_name": "한세광",
  "certificate": [
    {
      "cert_number": "20170108905",
      "changes": "",
      "disclosure_date": "2017-07-28",
      "first_cert_date": "2017-07-28",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2017-07-28 ~ 2019-07-27"
    },
    {
      "cert_number": "20190109270",
      "changes": "",
      "disclosure_date": "2019-08-09",
      "first_cert_date": "2017-07-28",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-07-28 ~ 2021-07-27"
    },
    {
      "cert_number": "20210916030002",
      "changes": "",
      "disclosure_date": "2021-09-16",
      "first_cert_date": "2017-07-28",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2021-07-28 ~ 2024-07-27"
    },
    {
      "cert_number": "20241002030057",
      "changes": "",
      "disclosure_date": "2024-10-02",
      "first_cert_date": "2017-07-28",
      "no": "4",
      "type": "혁신성장유형",
      "valid_period": "2024-07-28 ~ 2027-07-27"
    }
  ],
  "company_name": "(주)화이바이오메드",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 1229124000,
      "cost_of_sales": 1354000,
      "current_assets": 2132303000,
      "current_liabilities": 20009000,
      "gross_profit": 225472000,
      "net_income": -418815000,
      "net_income_bs": -418815000,
      "non_current_assets": 1606011000,
      "non_current_liabilities": 1438219000,
      "non_operating_expenses": 58840000,
      "non_operating_income": 53785000,
      "operating_profit": -413760000,
      "revenue": 226826000,
      "sga_expenses": 639232000,
      "total_assets": 3738314000,
      "total_equity": 2280086000,
      "total_liabilities": 1458228000
    },
    "2023": {
      "capital_stock": 1229125000,
      "cost_of_sales": 5166000,
      "current_assets": 2091895000,
      "current_liabilities": 52188000,
      "gross_profit": 154141000,
      "net_income": -213771000,
      "net_income_bs": -213771000,
      "non_current_assets": 1793706000,
      "non_current_liabilities": 1767097000,
      "non_operating_expenses": 57411000,
      "non_operating_income": 79508000,
      "operating_profit": -235868000,
      "revenue": 159307000,
      "sga_expenses": 390009000,
      "total_assets": 3885601000,
      "total_equity": 2066316000,
      "total_liabilities": 1819285000
    },
    "2024": {
      "capital_stock": 1229124000,
      "cost_of_sales": 11400000,
      "current_assets": 1665599000,
      "current_liabilities": 91524000,
      "gross_profit": 10100000,
      "net_income": -366879000,
      "net_income_bs": -366879000,
      "non_current_assets": 1846731000,
      "non_current_liabilities": 1721370000,
      "non_operating_expenses": 75942000,
      "non_operating_income": 62214000,
      "operating_profit": -353151000,
      "revenue": 21500000,
      "sga_expenses": 363251000,
      "total_assets": 3512330000,
      "total_equity": 1699436000,
      "total_liabilities": 1812894000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "히알루론산 유도체 개발 및 제조",
  "phone": "070-5220-****",
  "years": [
    2024,
    2023,
    2022
  ]
}